<DOC>
	<DOC>NCT00604344</DOC>
	<brief_summary>This trial is conducted in Japan. The aim of this trial is to investigate the efficacy of insulin detemir on blood glucose control in subjects with insulin requiring diabetes.</brief_summary>
	<brief_title>Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin, beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin, Human</mesh_term>
	<mesh_term>Insulin, Isophane</mesh_term>
	<criteria>Duration of diabetes mellitus for at least 2 years Current treatment of basalbolus regimen for at least 12 weeks using an intermediate/longacting human insulin and insulin aspart HbA1C below 11.0% Impaired renal function Impaired hepatic function Serious heart diseases Known hypoglycaemia unawareness or recurrent major hypoglycaemia Proliferative retinopathy or maculopathy requiring acute treatment Uncontrolled treated/untreated hypertension Current treatment with total insulin dose of more than 100 IU/day Current treatment or expected at the screening to start treatment with systemic corticosteroids</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>